Involvement of NF-κB activation in the induction of type II nitric oxide synthase in human glioblastoma cells

被引:1
|
作者
Kobayashi, M [1 ]
Suzuki, T [1 ]
Suzuki, I [1 ]
Liou, SY [1 ]
Hashimoto, Y [1 ]
Hashimoto, K [1 ]
机构
[1] Nippon Glaxo Ltd, Tsukuba Res Labs, Tsukuba, Ibaraki 3004247, Japan
来源
BIOMEDICAL RESEARCH-TOKYO | 1998年 / 19卷 / 02期
关键词
D O I
10.2220/biomedres.19.117
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Nitric oxide (NO) produced by glial cells has been implicated in the pathogenesis of neurodegenerative diseases. In human glial cells, the transcriptional mechanism of inducible NO synthase (iNOS) remains to be understood. We examined the role of the transcription factor NF-xB in the induction of iNOS in a human glioblastoma cell line, A-172. Treatment of A-172 cells with lipopolysaccharide (LPS), interleukin-1 beta (IL-1 beta) and interferon-gamma (IFN-gamma) induced iNOS mRNA and protein expression subsequent to the degradation of I Chi B, a protein that inhibits NF-Chi B, and the DNA binding of NF-Chi B. Furthermore, the antioxidant pyrroridine dithiocarbamate (PDTC), which is known to inhibit NF-Chi B activation, inhibited nitrite production in a dose-dependent manner. The inhibitory effect of PDTC correlated with the prevention of I Chi B degradation. Another antioxidant, nordihydroguaiaretic acid (NDGA), also inhibited the nitrite formation and iNOS mRNA expression through its preventive effect on NF-Chi B activation. These results suggest the involvement of NF-Chi B activation in iNOS induction in human glial cells.
引用
收藏
页码:117 / 126
页数:10
相关论文
共 50 条
  • [21] Hyperhomocysteinemia activates NF-κB and inducible nitric oxide synthase in the kidney
    Zhang, F
    Siow, YL
    O, K
    KIDNEY INTERNATIONAL, 2004, 65 (04) : 1327 - 1338
  • [22] Regulation of NF-κB binding in human endothelial cells by nitric oxide.
    Armstead, YE
    Minchenko, A
    Lefer, AM
    FASEB JOURNAL, 1998, 12 (04): : A473 - A473
  • [23] Trypanocidal drug benznidazole impairs lipopolysaccharide induction of macrophage nitric oxide synthase gene transcription through inhibition of NF-κB activation
    Piaggio, E
    Sancéau, J
    Revelli, S
    Bottasso, O
    Wietzerbin, J
    Serra, E
    JOURNAL OF IMMUNOLOGY, 2001, 167 (06): : 3422 - 3426
  • [24] Synergistic activation of NF-κB and inducible isoform of nitric oxide synthase induction by interferon-γ and tumor necrosis factor-α in INS-1 cells
    Sekine, N
    Ishikawa, T
    Okazaki, T
    Hayashi, M
    Wollheim, CB
    Fujita, T
    JOURNAL OF CELLULAR PHYSIOLOGY, 2000, 184 (01) : 46 - 57
  • [25] Involvement of protein kinase Cζ in interleukin-1β induction of ADAMTS-4 and type 2 nitric oxide synthase via NF-κB signaling in primary human osteoarthritic chondrocytes
    Chockalingam, Priya S.
    Varadarajan, Usha
    Sheldon, Richard
    Fortier, Eric
    LaVallie, Edward R.
    Morris, Elisabeth A.
    Yaworsky, Paul J.
    Majumdar, Manas K.
    ARTHRITIS AND RHEUMATISM, 2007, 56 (12): : 4074 - 4083
  • [26] The kinetics and regulation of the induction of type II nitric oxide synthase and nitric oxide in human fetal glial cell cultures
    M Ding
    J E Merrill
    Molecular Psychiatry, 1997, 2 : 117 - 119
  • [27] The kinetics and regulation of the induction of type II nitric oxide synthase and nitric oxide in human fetal glial cell cultures
    Ding, M
    Merrill, JE
    MOLECULAR PSYCHIATRY, 1997, 2 (02) : 117 - 119
  • [28] NF-κB, inducible nitric oxide synthase and apoptosis by Helicobacter pylori infection
    Lim, JW
    Kim, H
    Kim, KH
    FREE RADICAL BIOLOGY AND MEDICINE, 2001, 31 (03) : 355 - 366
  • [29] Complex regulation of human inducible nitric oxide synthase gene transcription by Stat 1 and NF-κB
    Ganster, RW
    Taylor, BS
    Shao, LF
    Geller, DA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (15) : 8638 - 8643
  • [30] Seat shock prevents cytokine-induced nitric oxide synthase expression by rat and human islets by inhibiting NF-κB activation
    Scarim, AL
    Heitmeier, MR
    Corbett, JA
    DIABETES, 1998, 47 : A266 - A266